We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s Dual-Antibody Injection Cuts Risk of COVID-19 Infection
AstraZeneca’s Dual-Antibody Injection Cuts Risk of COVID-19 Infection
AstraZeneca’s one-time dual-antibody injection cut the risk of symptomatic COVID-19 by up to 83 percent and the risk of severe disease by 88 percent in two studies of high-risk patients.